Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Kinase Inhibition by the Jamaican Ball Moss, Tillandsia recurvata L.

HENRY I.C. LOWE, CHARAH T. WATSON, SIMONE BADAL, NGEH J. TOYANG and JOSEPH BRYANT
Anticancer Research October 2012, 32 (10) 4419-4422;
HENRY I.C. LOWE
1Bio-Tech R&D Institute, Kingston, Jamaica
2Educational and Scientific Corporation, Lauderhill, FL, U.S.A.
3Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHARAH T. WATSON
1Bio-Tech R&D Institute, Kingston, Jamaica
4Natural Products Institute, University of the West Indies, Mona, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMONE BADAL
1Bio-Tech R&D Institute, Kingston, Jamaica
4Natural Products Institute, University of the West Indies, Mona, Jamaica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: simone.badal{at}uwimona.edu.jm
NGEH J. TOYANG
2Educational and Scientific Corporation, Lauderhill, FL, U.S.A.
3Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSEPH BRYANT
3Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background: This research was undertaken in order to investigate the inhibitory potential of the Jamaican ball moss, Tillandsia recurvata against several kinases. The inhibition of these kinases has emerged as a potential solution to restoring the tight regulation of normal cellular growth, the loss of which leads to cancer cell formation. Materials and Methods: Kinase inhibition was investigated using competition binding (to the ATP sites) assays, which have been previously established and authenticated. Results: Four hundred and fifty one kinases were tested against the Jamaican ball moss extract and a dose-response was tested on 40 kinases, which were inhibited by more than 35% compared to the control. Out of the 40 kinases, the Jamaican ball moss selectively inhibited 5 (CSNK2A2, MEK5, GAK, FLT and DRAK1) and obtained Kd50s were below 20 μg/ml. Conclusion: Since MEK5 and GAK kinases have been associated with aggressive prostate cancer, the inhibitory properties of the ball moss against them, coupled with its previously found bioactivity towards the PC-3 cell line, makes it promising in the arena of drug discovery towards prostate cancer.

  • Jamaican ball moss
  • Tillandsia recurvata
  • kinase inhibition
  • cancer

Being the third leading cause of death worldwide (1-3), cancer is anticipated to claim more lives as it is projected that by 2030, there will be approximately 26 million new cancer cases and 17 million cancer deaths per year (4). Cancer is the leading cause of death in Jamaica and latest cancer statistics showed that breast cancer is the leading cause of cancer mortality amongst Jamaican women, while Jamaican men have arguably the highest reported cases of prostate cancer in the world (5).

Normal cell growth is tightly regulated and this tight regulation is facilitated by various checkpoint systems of whom selected kinases are the most noted. This regulation allows for controlled growth, differentiation along with identification and problem solving of genomic alterations (6, 7) within the cell. When this phenomenon is out of balance, which can be as a result of carcinogenesis or hereditary predisposition, then there is a classic case of de-regulated cell proliferation resulting in what we know as cancer. It has, therefore, become a recent and therapeutically relevant direction to locate molecular entities, be them inducers or inhibitors that can regulate particular kinases in hope of restoring the normal balance to cell proliferation (8). This is believed to provide a solution to uncontrollable growth evidenced in malignant tumours. With this in mind this research was undertaken in order to investigate the inhibitory properties of the Jamaican ball moss, Tillandsia recurvata L. against 451 kinases. We report, for the first time, findings on those kinases that were most significantly inhibited in the presence of the Jamaican ball moss.

Jamaica is known for its rich biodiversity and its abundant usage of medicinal plants, with approximately 30% of its terrestrial plants being endemic (9). Medicinal plants continue to play a role in drug discovery and development because of vast structural diversity of molecules, some of which become new drugs or leads for the development of new drugs (10). Tillandsia recurvata L. (Bromeliaceae) which is commonly called the “Jamaican Ball Moss” or the “Old Man's beard” is one of the several important plants found in Jamaica. Previous work done in our lab showed that the Jamaican ball moss exhibits both anti-cancer and anti-inflammatory activities (11, 12). Mechanistic studies further showed that its anticancer activity was expressed through the induction of apoptosis in five cancer cell lines (namely; PC-3 prostate cancer; Kaposi Sarcoma, B-cell lymphoma, breast cancer, and B-16 melanoma (11), and recent research showed that extracts from this plant also reducs angiogenesis (accepted for publication by Lowe et al., 2012). The ability of this plant to exhibit cytototoxic properties against several cancer cell lines, coupled with its ability to activate programmed cell death, reduce angiogenesis and further be able to inhibit several kinases, is indicative that it may be an effective therapeutic solution to several cancers.

Materials and Methods

Kinase inhibition assay. Competition binding assays were established, authenticated and executed as described previously (13, 14). For most assays, kinases were fused to T7 phage strains (13) and for the other assays, kinases were produced in HEK-293 cells after which they were tagged with DNA for quantitative PCR detection (data not shown). In general, full-length constructs were used for small-, single-domain kinases, and catalytic domain constructs for large multi-domain kinases. The binding assays utilized streptavidin-coated magnetic beads treated with biotinylated small-molecule ligands for 30 min at room temperature which generated affinity resins for the kinase assays. The liganded beads were blocked with excess biotin and washed with blocking buffer (SeaBlock (Pierce), 1% BSA, 0.05 % Tween 20, 1 mM DTT) to remove unbound ligand and to reduce non-specific phage binding. Binding reactions were assembled by combining kinases, liganded affinity beads, and test compounds in 1× binding buffer (20% SeaBlock, 0.17× PBS, 0.05% Tween 20, 6 mM DTT). Test compounds were prepared as 40x stocks in 100% DMSO and were diluted directly into the assay (Final DMSO concentration=2.5%). All reactions were performed in polypropylene 384-well plates in a final volume of 0.04 ml. The assay plates were incubated at room temperature with shaking for 1 h and the affinity beads were washed with washing buffer (1 × PBS, 0.05% Tween 20). The beads were then re-suspended in elution buffer (1 × PBS, 0.05% Tween 20, 0.5 μM non-biotinylated affinity ligand) and incubated at room temperature with shaking for 30 min. The kinase concentration in the eluates was measured by quantitative PCR. Figure 1 presents a graphical illustration of the kinase interaction process. Kd50s were determined using a standard dose-response curve using the hill equation. Curves were fitted using a non-linear least square fit with the Levenberg-Marquardt algorithm.

Plant material. Tillandsia recurvata extraction. The whole T. recurvata plant was collected from trees and electricity poles at Kingston, Jamaica. A voucher specimen of the plant was identified at the Institute of Jamaica Herbarium where it is deposited with Accession Number: IJ 3411. The collected plant material was air-dried, pulverized into powder. 2.3 kg of Ball Moss biomass was extracted twice with 5 L of chloroform. The filtrate was dried in a rotavapor to obtain a dark green residue (87.6 g).

Results and Discussion

Out of the 451 kinases tested, a dose-response was run on 40 which were inhibited by more than 35%, compared to the controls. Out of the 40 kinases, the Jamaican ball moss selectively inhibited 5 (MEK5, GAK, CSNK2A2, FLT and DRAK1) and obtained a Kd50<20 μg/ml, as shown in Table I.

Mitogen/extracellular signal-regulated kinase-5 (MEK5) belongs to a network of mitogen-activated protein kinase pathways while Cyclin G-associated kinase (GAK) is identified as an androgen receptor (AR) protein belonging to the steroid receptor family. Both of these kinases have been associated with the process of carcinogenesis (15, 16) and their further overexpression has been shown to promote cellular proliferation, motility and invasion (17), linking them to aggressive prostate (15, 18) and breast cancers (19). Since previous work performed in our laboratory demonstrated that the ball moss extract reduced the viability of a human prostate cancer cell line (PC-3) via apoptosis (11), its further bioactivity towards the inhibition of MEK5 (Kd50=12 μg/ml) and GAK (Kd50=8 μg/ml), kinases associated with aggressive prostate cancer makes this plant extract even more relevant in the arena of drug discovery against this cancer.

Present in all eukaryotic cells, casein kinase II (CSNKA2) is a highly conserved (20, 21) multifunctional protein kinase that catalyzes the phosphorylation of amino acids, serine and threonine (22), and is implicated in a variety of cellular processes and functions including mitosis and cellular transformation. It has been shown to be expressed in several cancers (23, 24), as well as in the pathogenesis of a number of infectious and neurodegenerative diseases and cardiovascular disorders (8, 25). Inhibition of this kinase, as demonstrated by the Jamaican ball moss (Kd50=14 μg/ml), implicates induction of the p53-dependent cell-cycle arrest and consequently apoptosis, as demonstrated by Dixit et al., (26). Also, since CSNKA2 is implicated in neurodegenerative diseases and cardiovascular disorders, then their inhibitors may show promise in the treatment of these diseases and disorders.

FMS-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase (TK) structurally related to the receptors for platelet-derived growth factor (PDGF), expressed by immature hematopoietic cells and is important for the normal development of stem cells and the immune system (27). Mutations of this kinase have been associated with leukemia (28) and so the search for molecular drug entities that can inhibit these mutated kinases is ongoing in hopes of finding a solution to cancers of the blood and immune system. The Jamaican ball moss inhibited this kinase (12 μg/ml) making it an ideal candidate for future research against the mutant variant and also making it an ideal candidate for further development in the treatment of the above cancers.

Among the five kinases inhibited by the Jamaican ball moss, was the kinase-related apoptosis inducing protein kinase 1 (DRAPK1, Kd50=12 μg/ml) a kinase known to enhance the cell's sensitivity, as well as overcoming its resistance to gemcitabine in pancreatic cancer cells (29). Because of the role this kinase plays in the promotion of apoptosis, inducers rather than inhibitors are the preferred traits of plant extracts/molecular entities, making the activity of the ball moss towards this particular kinase not ideal. Notwithstanding, the search for key phytochemicals from the Jamaican ball moss such as isolated cycloartanes (submitted for publication, Lowe et al., 2012) and a novel glycoside (30) previously conducted in our lab can be explored for induction properties towards this particular kinase.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

How the KinomeScan assay works (Courtesy of DiscoveRx).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Kinases showing good interaction with Ball Moss and their disease relevance.

Conclusion

Out of the 451 kinases, the Jamaican ball moss selectively inhibited 5, thus validating its potential anticancer activity. Our findings show that the bioactivity of the Jamaican ball moss inhibits two of the tested kinases, MEK5 and GAK, known to be associated with prostate cancer. Coupled with previous findings that demonstrate the bioactivity of the plant extract to apoptotically reduce the viability of a human prostate cancer cell line the present results are promising in the arena of drug discovery towards prostate cancer.

Acknowledgements

The Authors are grateful to Dr. Rena Lapidus of the Translational Core of the Greenebaum Cancer Center, University of Maryland School of Medicine for validating the results of the anticancer activity of Cycloartane-3,24,25-triol and to the KINOMEscan group (San Diego) for carrying out the kinase inhibition assays.

  • Received July 31, 2012.
  • Accepted August 31, 2012.
  • Copyright© 2012 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. American Cancer Society
    : &quot;Report sees 7.6 million global 2007 cancer deaths (last updated on August, 7 2008). <http://enwikipediaorg/wiki/Reuters>2007.
    1. Reinberg S
    . Cancer Killed Almost 8 Million Worldwide in 2007.
  2. ↵
    1. World Health Organization
    : Cancer. Available at http://wwwwhoint/mediacentre/factsheets/fs297/en/ Retrieved on 2007-06-25 2006.
  3. ↵
    1. Boyle P,
    2. Levin B
    . World Cancer Report, 2008. In: Available at http://appswhoint/bookorders/anglais/detart1jsp?sesslan=1&codlan=1&codcol=76&codcch=26Lyon: IARC Press2008.
  4. ↵
    1. Gibson T,
    2. Blake G,
    3. Hanchard B,
    4. Waugh N,
    5. D M
    : Age-Specific Incidence of Cancer in Kingston and St Andrew, Jamaica, 1998-2002. West Indian Med J 57: 81-89, 2008.
    OpenUrlPubMed
  5. ↵
    1. Norbury C,
    2. Nurse P
    : Animal cell cycles and their control. Annual Review of Biochemistry 61: 441-470, 1992.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Nurse P,
    2. Masui Y,
    3. Hartwell L
    : Understanding the cell cycle. Nature Medicine 4: 1103-1106, 1998.
    OpenUrlCrossRefPubMed
  7. ↵
    1. Cohen P
    : Protein kinases – the major drug targets of the twenty-first century? Nature Reviews Drug Discovery 1: 309-315, 2002.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Mitchell S,
    2. Ahmad M
    : A Review of Medicinal Plant Research at the University of the West Indies, Jamaica, 1948-2001. West Indies Medical Journal 55: 243-269, 2006.
    OpenUrl
  9. ↵
    1. Gordaliza M
    : Natural products as leads to anticancer drugs. Clin Transl Oncol 9: 767-776, 2007.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Lowe H
    : Anti-tumor and anti-inflammatory extracts of plant biomass and their uses. edited by Patent US. Jamaica pp. 1-14, 2010.
  11. ↵
    1. Lowe H
    : Anti-tumor and anti-inflammatory extracts of plant biomass and their uses. US Patent #7,713,556 2008.
  12. ↵
    1. Fabian MA,
    2. Biggs WH III.,
    3. Treiber DK,
    4. Atteridge CE,
    5. Azimioara MD,
    6. Benedetti MG,
    7. Carter TA,
    8. Ciceri P,
    9. Edeen PT,
    10. Floyd M,
    11. Ford JM,
    12. Galvin M,
    13. Gerlach JL,
    14. Grotzfeld RM,
    15. Herrgard S,
    16. Insko DE,
    17. Insko MA,
    18. Lai AG,
    19. Lélias J-M,
    20. Mehta SA,
    21. Milanov ZV,
    22. Velasco AM,
    23. Wodicka LM,
    24. Patel HK,
    25. Zarrinkar PP,
    26. Lockhart DJ
    : A small molecule-kinase interaction map for clinical kinase inhibitors. Nature Biotechnology 23: 329-336, 2005.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Karaman MW,
    2. Herrgard S,
    3. Treiber DK,
    4. Gallant P,
    5. Atteridge CE,
    6. Campbell BT,
    7. Chan KW,
    8. Ciceri P,
    9. Davis MI,
    10. Edeen PT,
    11. Faraoni R,
    12. Floyd M,
    13. Hunt JP,
    14. Lockhart DJ,
    15. Milanov ZV,
    16. Morrison MJ,
    17. Pallares G,
    18. Patel HK,
    19. Pritchard S,
    20. Wodicka LM,
    21. Zarrinkar PP
    : A quantitative analysis of kinase inhibitor selectivity. Nature Biotechnology 26: 127-132, 2008.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Ray MR,
    2. Wafa LA,
    3. Cheng H,
    4. Snoek R,
    5. Fazil L,
    6. Gleave M,
    7. Rennie PS
    : Cyclin G-associated kinase: A novel androgen receptor-interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer. Int J Cancer 118: 1108-1119, 2006.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Diao D,
    2. Wang L,
    3. Zhang J,
    4. Chen D,
    5. Liu H,
    6. Wei Y,
    7. Lu J,
    8. Peng J,
    9. Wang J
    : Mitogen/extracellular signal-regulated kinase kinase-5 promoter region polymorphisms affect the risk of sporadic colorectal cancer in a southern Chinese population. DNA Cell Biol 31: 342-349, 2012.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Mehta PB,
    2. Jenkins BL,
    3. McCarthy L,
    4. Thilak L,
    5. Robson CN,
    6. Neal DE,
    7. Leung HY
    : MEK5 overexpression is associated wth metastatic protate cancer and stimulates proliferation, MMP-9 expression and invasion. Oncogene 22: 1381-1389, 2003.
    OpenUrlCrossRefPubMed
  17. ↵
    1. McCracken SRC,
    2. Ramsay A,
    3. Heer R,
    4. Mathers ME,
    5. Jenkins BL,
    6. Edwards J,
    7. Robson CN,
    8. Marquez R,
    9. Cohen P,
    10. Leung HY
    : Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancerERK5 expression in human prostate cancer. Oncogene 27: 2978-2988, 2008.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Esparís-Ogando A,
    2. Díaz-Rodríguez E,
    3. Montero JC,
    4. Yuste L,
    5. Crespo P,
    6. Pandiella A
    : Cell growth and development Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol 22: 1270-1285, 2002.
    OpenUrl
  19. ↵
    1. Padmanabha R,
    2. Chen-Wu JL,
    3. Hanna DE,
    4. Glover CV
    : Isolation, sequencing, and disruption of the yeast CKA2 gene: casein kinase II is essential for viability in Saccharomyces cerevisiae. Mol Cell Biol 10: 4089-4099, 1990.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    1. Kikkawa U,
    2. Mann SK,
    3. Firtel RA,
    4. Hunter T
    : Molecular cloning of casein kinase II alpha subunit from Dictyostelium discoideum and its expression in the life cycle. Mol Cell Biol 12: 5711-5723, 1992.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Lozeman F,
    2. Litchfield D,
    3. C P,
    4. Takio K,
    5. Walsh K,
    6. Krebs E
    : Isolation and characterization of human cDNA clones encoding the α and the α1 subunits of casein kinase II. Biochemistry 29: 8436-8447, 1990.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Faust R,
    2. Niehans G,
    3. Gapany M,
    4. Hoistad D,
    5. Knapp D,
    6. Cherwitzb D,
    7. Davisa A,
    8. Adamsc GL,
    9. Ahmeda K
    : Subcellular immunolocalization of protein kinase CK2 in normal and carcinoma cells. Int Int J Biochem Cell Biol 31: 941-949, 1999.
    OpenUrlPubMed
  23. ↵
    1. Landesman-Bollag E,
    2. Romieu-Mourez R,
    3. Song D,
    4. Sonenshein GE,
    5. Cardiff RD,
    6. Seldin DC
    : Protein kinase CK2 in mammary gland tumorigenesis. Oncogene 20: 3247-3257, 2001.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Knippschild U,
    2. Gocht A,
    3. Wolff S,
    4. Huber N,
    5. Lfhler J,
    6. Stfter M
    : The casein kinase 1 family: participation in multiple cellular processes in eukaryotes. Cellular Signalling 17: 675-689, 2005.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Dixit D,
    2. Sharma V,
    3. Ghosh S,
    4. Mehta VS,
    5. Sen E
    : Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFα)-induced apoptosis through SIRT1 inhibition. Cell Death and Disease 3: 271-282, 2012.
    OpenUrl
  26. ↵
    1. IIImer T,
    2. Ehninger G
    : FMS-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase (TK) expressed by immature hematopoietic cells and is important for the normal development of stem cells and the immune system. M. Clin Lymphoma Myeloma 8: S24-S34, 2007.
    OpenUrl
  27. ↵
    1. Stone RM,
    2. DeAngelo DJ,
    3. Klimek V,
    4. Galinsky I,
    5. Estey E,
    6. Nimer SD,
    7. Grandin W,
    8. Lebwohl D,
    9. Wang Y,
    10. Cohen P,
    11. Fox EA,
    12. Neuberg D,
    13. Clark J,
    14. Gilliland DG,
    15. Griffin JD
    : Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 Blood 105: 54-60, 2005.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Guo Q,
    2. Chen Y,
    3. Wu Y
    : Enhancing apoptosis and overcoming resistance of gemcitabine in pancreatic cacner with bortezomib: a role of death-associated protein kinase-related apoptosis-inducing protein kinase 1. Tumori 95: 796-803, 2009.
    OpenUrlPubMed
  29. ↵
    1. Lowe H,
    2. Watson C,
    3. Badal S,
    4. Toyang N,
    5. Bryant J
    : Isolation, purification and partial characterization of a glycoside from the Jamaican ball moss plant (Tillandsia recurvata L.). Advances in Biological Chemistry (accepted for publication): 2012.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 32, Issue 10
October 2012
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Kinase Inhibition by the Jamaican Ball Moss, Tillandsia recurvata L.
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
5 + 15 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Kinase Inhibition by the Jamaican Ball Moss, Tillandsia recurvata L.
HENRY I.C. LOWE, CHARAH T. WATSON, SIMONE BADAL, NGEH J. TOYANG, JOSEPH BRYANT
Anticancer Research Oct 2012, 32 (10) 4419-4422;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Kinase Inhibition by the Jamaican Ball Moss, Tillandsia recurvata L.
HENRY I.C. LOWE, CHARAH T. WATSON, SIMONE BADAL, NGEH J. TOYANG, JOSEPH BRYANT
Anticancer Research Oct 2012, 32 (10) 4419-4422;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Conclusion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Antileukemic Activity of Tillandsia recurvata and Some of its Cycloartanes
  • Specific RSK Kinase Inhibition by Dibenzyl Trisulfide and Implication for Therapeutic Treatment of Cancer
  • Google Scholar

More in this TOC Section

  • Silencing of β-TrCP2 Suppresses Growth and G1/S Cell Cycle Progression in Non-small Cell Lung Carcinoma Cells
  • Molecular Features of Gastrointestinal Stromal Tumors: A Single Referral Cancer Center Experience
  • Targeting AURKB Attenuates Tumor Growth in MYC-driven Lung Adenocarcinoma
Show more Experimental Studies

Keywords

  • Jamaican ball moss
  • Tillandsia recurvata
  • kinase inhibition
  • cancer
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire